DN vs. CTX, VPH, WLLW, TMD, and AEZS Should you be buying Delta 9 Cannabis stock or one of its competitors? The main competitors of Delta 9 Cannabis include Crescita Therapeutics (CTX), Valeo Pharma (VPH), Willow Biosciences (WLLW), Titan Medical (TMD), and Aeterna Zentaris (AEZS). These companies are all part of the "medical" sector.
Crescita Therapeutics (TSE:CTX ) and Delta 9 Cannabis (TSE:DN ) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation.
Which has more volatility & risk, CTX or DN?
Crescita Therapeutics has a beta of 1.65, indicating that its share price is 65% more volatile than the S&P 500. Comparatively, Delta 9 Cannabis has a beta of 1.34, indicating that its share price is 34% more volatile than the S&P 500.
Do analysts recommend CTX or DN?
Is CTX or DN more profitable?
Crescita Therapeutics has a net margin of -11.33% compared to Crescita Therapeutics' net margin of -24.65%. Delta 9 Cannabis' return on equity of -9.95% beat Crescita Therapeutics' return on equity.
Does the MarketBeat Community favor CTX or DN?
Crescita Therapeutics received 51 more outperform votes than Delta 9 Cannabis when rated by MarketBeat users. However, 100.00% of users gave Delta 9 Cannabis an outperform vote while only 67.42% of users gave Crescita Therapeutics an outperform vote.
Which has stronger valuation & earnings, CTX or DN?
Crescita Therapeutics has higher earnings, but lower revenue than Delta 9 Cannabis. Crescita Therapeutics is trading at a lower price-to-earnings ratio than Delta 9 Cannabis, indicating that it is currently the more affordable of the two stocks.
Does the media favor CTX or DN?
In the previous week, Delta 9 Cannabis had 1 more articles in the media than Crescita Therapeutics. MarketBeat recorded 2 mentions for Delta 9 Cannabis and 1 mentions for Crescita Therapeutics. Crescita Therapeutics' average media sentiment score of 0.55 beat Delta 9 Cannabis' score of 0.00 indicating that Delta 9 Cannabis is being referred to more favorably in the news media.
Summary Crescita Therapeutics beats Delta 9 Cannabis on 7 of the 12 factors compared between the two stocks.
This chart shows the number of new MarketBeat users adding DN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Delta 9 Cannabis Competitors List
Related Companies and Tools